Category Archives: Uncategorized

14 Mar

Charged With Fraud, Theranos CEO Elizabeth Holmes Cuts Deal with Feds

Charged with what the U.S. Securities and Exchange Commission called “massive fraud,” Theranos CEO Elizabeth Holmes has cut a deal

14 Mar

ICER Comes Under Renewed Scrutiny

As we enter a new and exciting era of medicine, there is an important question we need to answer: What

14 Mar

Crinetics Closes $63.5M Financing to Back Rare Hormone Disease Drug

Crinetics Pharmaceuticals, a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it

13 Mar
13 Mar

Two new biotech related podcast episodes. I would love some feedback.

One week since I launched the podcast and there has been a lot of buzz. I want to thank everyone

13 Mar

Goldfinch Bio Names Peter Mundel Chief Scientific Officer

Goldfinch Bio has appointed Peter Mundel to serve as chief scientific officer of the Cambridge, MA, kidney disease drug developer.

13 Mar

National Women’s History Month: Rosalind Franklin Nomination Opens

Each March, the U.S. celebrates National Women’s History Month, recognizing the great contributions women have made to our nation. It’s

13 Mar

Nasdaq’s Head of Healthcare Listings Shares 2018 Predictions for Biotech IPOs

Nasdaq: What is the current market environment for biotech initial public offerings and biotech listings overall? Saxe: I expect that

12 Mar

Information and Communication Technologies

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-ICT-2018-2020Pillar: Industrial LeadershipPlanned Opening Date: Deadline: Wed, 14 Nov 2018 17:00:00 (Brussels local time)Modification Date: Mon, 12

12 Mar

Gilead CSO Bischofberger to Step Down, McHutchison Named Successor

Norbert Bischofberger, executive vice president of research and development and chief scientific officer of Gilead Sciences (NASDAQ: GILD), is stepping